Clinical Trials · NCT06937749

A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Name: A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Active Not RecruitingPhase 2Mazdutide

Phase: Phase 2
Recruitment status: Active Not Recruiting
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Enrollment: 181
Start date: Jun 2025
Locations: 1 site, China
Primary endpoint: Percentage of Participants With MASH resolution With no Worsening of Fibrosis on Liver Histology

View Mazdutide compound reference